MedVi vs Skinny RX: Compare GLP-1 Programs & Pricing
Side-by-side MedVi and Skinny RX: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
MedVi and Skinny RX are telehealth providers that offer access to GLP-1–based therapies through virtual consultations and licensed pharmacies. This comparison focuses on program structure, pricing starting points, promotional offers, and clinical oversight to help you decide which service aligns with your needs.
MedVi vs Skinny RX: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| MedVi | $179.00 | $279.00 | $120 off first month | No |
| Skinny RX | $199.00 | $299.00 | Oral & Injectable GLP-1 plans | No |
MedVi vs Skinny RX: How the Programs Work
Both providers use telehealth intake forms followed by clinician review. Patients complete medical history and symptom questionnaires; licensed clinicians evaluate eligibility and, if appropriate, issue prescriptions. Neither MedVi nor Skinny RX will dispense medications without a clinical assessment, and both follow state telemedicine regulations.
Follow-up frequency and support vary. Some plans emphasize one-time consultations with medication delivery, while others include scheduled check-ins and dosage adjustments. Confirm the exact level of monitoring and follow-up before enrolling, especially if you have complex medical conditions.
MedVi vs Skinny RX: Pricing Comparison
MedVi lists semaglutide starting at $179.00 and tirzepatide starting at $279.00. Skinny RX lists semaglutide from $199.00 and tirzepatide from $299.00. The lower starting prices are highlighted to help with quick comparison.
Promotions differ: MedVi advertises “$120 off first month” while Skinny RX promotes both oral and injectable GLP-1 plan options. Membership fees are not required for either provider according to current listings, but make sure to check for any updates or bundled program fees during signup.
MedVi vs Skinny RX: Clinical Oversight & Safety
Both platforms connect patients with licensed U.S. clinicians who make prescribing decisions based on medical history, current medications, and any contraindications. Telehealth assessments are intended to replicate in-person clinical decision-making but may include limitations based on state laws and provider protocols.
Book a Consultation with MedVi
Important safety notes: compounded GLP-1 formulations are not identical to branded, FDA-approved products (for example, Wegovy 4 and Mounjaro 4) and may differ in formulation or dosing. Prescriptions should only be filled after a clinician confirms suitability. Report side effects promptly and follow clinician instructions for dose titration.
Learn About Safety with Skinny RX
MedVi vs Skinny RX: Customer Experience & Delivery
Patient feedback often highlights affordability and speed for MedVi, with users noting straightforward onboarding. Skinny RX reviews commonly reference attentive clinical communication and structured follow-up. Delivery timelines vary but typically range from several days to about a week after prescription approval.
MedVi vs Skinny RX: Final Verdict
If your priority is the lowest starting price and fast onboarding, MedVi may be the better fit with semaglutide from $179.00 and tirzepatide from $279.00. If you prefer a program emphasizing follow-up and multiple formulation options (oral and injectable), Skinny RX could be more appropriate despite slightly higher starting costs.
Join MedVi Get Started with Skinny RX
Disclaimer
This article is for informational purposes only and is not medical advice. All prescriptions must come from a licensed clinician following a proper telehealth evaluation. Compounded GLP-1 products may not be identical to branded, FDA‑approved medications. Always consult a licensed healthcare professional before starting any medication or treatment. GLP1Talks & GLP1Discussions may receive affiliate commissions at no additional cost to you.